This site uses cookies. By continuing to browse the site without disabling them, you consent to our use of cookies. To learn more about the types of cookies we use, please view our cookie policy.

Indivior
  • Product Query or Adverse Event
  • Careers
  • Contact Us
  • Locations
  • International
  • About
    • History
    • Leadership
  • Diseases of Addiction
    • A Worldwide Crisis
    • The Patient Journey
  • R & D
    • Publications
    • White Papers
    • Abstracts
    • Grants
  • Products
  • Responsibility
    • Environment, Climate Change and Health and Safety
    • Communities
    • Patient Safety and Product Quality
    • Corporate Integrity Agreement
    • Integrity & Compliance
    • Business Conduct
    • People
    • Advocacy and Stakeholder Engagement
    • Transparency Program
  • Investors
  • Media
  • Investor Information
    • Annual Reports
    • Press Releases
    • RNS Filings
    • RNS Filings (Inside Information)
    • SEC Filings
    • Corporate Alert Service
    • Webcasts / Audiocasts / Presentations
    • Prospectus
    • Upcoming Events
    • Buprenorphine Market Modeling Methodology
  • Share Price
    • Share Price Center
    • Share Price Table
    • Historic Share Price
    • Share Price Calculator
    • Demerger: Base Cost
  • Corporate Governance
    • UK Corporate Governance Code
    • Leadership
    • The Board
    • Board Committees
    • Executive Committees
    • Risk Management and Internal Control
    • Indivior Integrity & Compliance Program
    • Integrity & Compliance
    • Corporate Responsibility
    • Tax Strategy
    • Global Conduct Policies
  • Shareholder Information
    • Managing Your Shareholding
    • Dividends
    • Annual General Meeting
    • American Depositary Receipts
  • Contact Us
  • Investor Information
    • Annual Reports
    • Press Releases
    • RNS Filings
    • RNS Filings (Inside Information)
    • SEC Filings
    • Corporate Alert Service
    • Webcasts / Audiocasts / Presentations
    • Prospectus
    • Upcoming Events
    • Buprenorphine Market Modeling Methodology
  • Share Price Information
    • Share Price Center
    • Share Price Table
    • Historic Share Price
    • Share Price Calculator
    • Demerger: Base Cost
  • Corporate Governance
    • UK Corporate Governance Code
    • Leadership
    • The Board
    • Board Committees
    • Executive Committees
    • Risk Management and Internal Control
    • Integrity & Compliance
    • Corporate Responsibility
    • Tax Strategy
    • Global Conduct Policies
  • Shareholder Information
    • Managing Your Shareholding
    • Dividends
    • Annual General Meeting
    • American Depositary Receipts
  • Contact Us

Investor News

Q1 2021 Results Webcast

The webcast can be accessed here on April 29, 2021 at 1300 BST / 8:00…

Read more

Annual Report and Notice of Annual General Meeting

You can access the link here.

Read more

Board Appointments and Succession Plan Announced

Read more

Indivior Recognizes Drug and Alcohol Facts Week® 2021

Read more

Indivior FY 2020 Financial Results Presentation

PDF presentation can be downloaded here.

Read more

Indivior Announces FY 2020 Financial Results

Read more

Indivior Reaches Settlement with Reckitt Benckiser

Read more

The Department of Health and Human Services Announces New Guidance Intended to Expand Access to Medication-Assisted Treatment for the Treatment of Opioid Use Disorder

Read more

Indivior Provides Preliminary FY 2020 Financial Results Ahead of Guidance

Read more

Indivior PLC – Directorate Change

Read more
Next Page »
  • About
  • Diseases of Addiction
  • R & D
  • Products
  • Responsibility
  • Investors
  • Media
  • MODERN SLAVERY STATEMENT (PDF)
  • Product Query or Adverse Event
  • Careers
  • Contact
  • Terms of Use
  • Privacy Policy
  • Accessibility
  • Privacy Policy and Notice for California Residents
  • International

© 2020 Indivior PLC | INDIVIOR is a registered trademark of Indivior UK Limited.

You are now leaving Indivior.com to visit Suboxone.com a US product site intended for US residents and healthcare professionals.

Continue    Return

You are now leaving Indivior.com.

Continue    Return

You are about to leave the Indivior website

The product specific Internet site that you have requested is intended for US audiences, as noted on that site. As a result, the site may contain information on pharmaceuticals that are not approved in other countries or regions.

Do you wish to continue to this product-specific site?

YES
I agree
NO
I disagree